Abstract:Background: Epithelial carcinoma is a subtype of ovarian cancers, with the highest lethality among all ovarian cancer subtypes. Hitherto surgical excision combined with chemotherapy has been the most extensively employed method in clinical treatment. However, the disease relapses very frequently, calling for more effective therapies. Mangiferin, a natural compound, has displayed promising anti-cancer activities by in vitro studies, but its therapeutic value in epithelial ovarian cancer treatment, either by in vivo or in vitro studies, remained to be known.Purpose: This study aimed to determine the suppressive activities of mangiferin on human epithelial ovarian cancer and elucidate the underlying molecular mechanisms.Study design and methods: We employed the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay and the crystal violet assay to determine the half maximal inhibitory concentration (IC50) values of mangiferin with paclitaxel as a positive control and the inhibitory effects of mangiferin on the proliferation of two human epithelial ovarian cancer cell lines. Wound healing and Transwell assays were used to determine anti-metastastic activities of mangiferin. ES-2 xenograft nude mouse model was used for the in vivo experiments. Western blotting, enzyme-linked immunosorbent assay (ELISA) and immunohistochemistry (IHC) assays were carried out for evaluating the expression level of matrix metalloproteinase 2 (MMP2) and matrix metalloproteinase 9 (MMP9).Results: In the present study, we demonstrated by both in vitro and in vivo assays that mangiferin suppressed the progress of epithelial ovarian cancer in a dose-dependent manner. In the animals treated with mangiferin, the tumor volume and weight were reduced significantly. Analyses of involved molecular events demonstrated that mangiferin down-regulated the expression of metastasis-associated proteins MMP2 and MMP9.Conclusion: Mangiferin strongly inhibited the progression of human epithelial ovarian cancer by down-regulating MMP2 and MMP9.<dl class="list"><dt class="list-label">•</dt><dd class="list-description">Mangiferin suppresses tumor progression in in-vivo experiments with no side effects.</dd><dt class="list-label">•</dt><dd class="list-description">Mangiferin inhibits the metastasis of epithelial ovarian cancer by down-regulating MMP2 and MMP9.</dd><dt class="list-label">•</dt><dd class="list-description">Mangiferin reduces the number of epithelial ovarian cancer cells at a relative low concentration and shows a significant inhibitory effect in clear cell carcinoma than paclitaxel in a high concentration.</dd></dl>

Ougan (citrus Reticulata Cv. Suavissima) Flavedo Extract Suppresses Cancer Motility by Interfering with Epithelial-to-mesenchymal Transition in SKOV3 Cells.

Chemopreventive Effect of Flavonoids from Ougan (citrus Reticulata Cv. Suavissima) Fruit Against Cancer Cell Proliferation and Migration

Polymethoxyflavones from citrus inhibited gastric cancer cell proliferation through inducing apoptosis by upregulating RARβ, both in vitro and in vivo

Mechanism of Sophorae Flavescentis Radix against ovarian cancer via new pharmacology, molecular docking, and experimental verification

Amentoflavone Triggers Cell Cycle G2/M Arrest by Interfering with Microtubule Dynamics and Inducing DNA Damage in SKOV3 Cells.

Flavonoid-rich Extracts from Okra Flowers Exert Antitumor Activity in Colorectal Cancer Through Induction of Mitochondrial Dysfunction-Associated Apoptosis, Senescence and Autophagy

Oblongifolin C Inhibits Metastasis by Up-Regulating Keratin 18 and Tubulins

Suppressive activities of mangiferin on human epithelial ovarian cancer

Clove Extract Inhibits Tumor Growth and Promotes Cell Cycle Arrest and Apoptosis.

Emblica officinalis extract downregulates pro-angiogenic molecules via upregulation of cellular and exosomal miR-375 in human ovarian cancer cells.

Ginger inhibits the invasion of ovarian cancer cells SKOV3 through CLDN7, CLDN11 and CD274 m6A methylation modifications

Flavonoids from Ougan (citrus Suavissima Hort. Ex Tanaka) Peel Exert Hypoglycemic Potency Through Inhibiting Insulin Resistance in HepG2 Cells and Regulating Gut Microbiota in Diabetic Mice

Chelerythrine induces apoptosis and ferroptosis through Nrf2 in ovarian cancer cells

Oroxylin A suppresses invasion through down-regulating the expression of matrix metalloproteinase-2/9 in MDA-MB-435 human breast cancer cells.

1α,25(OH)2D3 Suppresses the Migration of Ovarian Cancer SKOV-3 Cells through the Inhibition of Epithelial–Mesenchymal Transition

Main components of pomegranate, ellagic acid and luteolin, inhibit metastasis of ovarian cancer by down-regulating MMP2 and MMP9.

Fraxetin suppresses the proliferation, migration, and invasion of ovarian cancer cells by inhibiting the TLR4/STAT3 signaling pathway

Myricetin Suppresses Ovarian Cancer In Vitro by Activating the p38/Sapla Signaling Pathway and Suppressing Intracellular Oxidative Stress

Inactivation of AKT, ERK and NF-κB by Genistein Derivative, 7-Difluoromethoxyl-5,4′-di-n-octylygenistein, Reduces Ovarian Carcinoma Oncogenicity

Compound Fuling Granule Suppresses Ovarian Cancer Development and Progression by disrupting mitochondrial function, galactose and fatty acid metabolism

A Luminacin D Analog HL142 Inhibits Ovarian Tumor Growth and Metastasis by Reversing EMT and Attenuating the TGFβ and FAK Pathways